Kingman Healthcare, INC

Kingman Healthcare, INC was paid $86.15M by Medicaid between Jan 2018 and Dec 2024, across 558 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoKINGMAN HEALTHCARE, INC
KINGMAN, AZ 86409

33aNPI1265423917assigned 11/02/2005

33bProvider typeHome Health Agency

28Total paid$86.15M

24GClaims2,433,576

24DCodes billed558

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Home Health Agency providers in Arizona

Rank by total paid#7 of 179

Median peer was paid$716K

This provider vs. median120×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	372,962	$12.28M
2019	367,501	$11.99M
2020	314,927	$11.38M
2021	371,297	$13.13M
2022	356,505	$13.99M
2023	361,922	$13.33M
2024incomplete	288,462	$10.06M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	54,056	48,698	$13.17M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	52,536	45,803	$12.14M
74177	Computed tomography, abdomen and pelvis; with contrast material	11%	25,881	24,190	$9.50M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.3%	18,716	15,955	$3.74M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	3.0%	2,595	2,338	$2.60M
70450	Computed tomography, head or brain; without contrast material	2.7%	21,671	19,797	$2.30M
71260	Computed tomography, thorax, diagnostic; with contrast material	2.0%	11,514	10,763	$1.74M
72125	Computed tomography, cervical spine; without contrast material	1.8%	6,407	5,881	$1.52M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.7%	13,843	12,826	$1.50M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.7%	48,464	18,558	$1.46M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.5%	1,640	1,562	$1.32M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	3,591	3,242	$1.29M

546 more codes

G0378	Hospital observation service, per hour	1.4%	21,505	$1.19M
0202U	Oncology (prostate), multianalyte, gene expression profiling	1.4%	6,436	$1.18M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.3%	2,207	$1.10M
94060		1.1%	3,998	$991K
95811		1.1%	1,946	$963K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,000	$762K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	21,437	$744K
70498		<1%	1,123	$736K
93971		<1%	4,171	$702K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,339	$695K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	10,513	$684K
74174		<1%	1,077	$647K
80050	General health panel	<1%	15,719	$603K
99214	Doctor's office visit, returning patient (more involved)	<1%	18,262	$600K
99232	Hospital visit by a doctor, follow-up day	<1%	14,707	$589K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	17,895	$583K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	12,875	$555K
72131		<1%	2,252	$554K
93458		<1%	299	$515K
93970		<1%	1,873	$488K
59025	Fetal non-stress test	<1%	3,370	$473K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	3,039	$434K
71046	Radiologic examination, chest; 2 views	<1%	35,818	$432K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	63,627	$431K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,079	$419K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	9,579	$410K
99213	Doctor's office visit, returning patient (routine)	<1%	17,554	$389K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	23,336	$387K
88307		<1%	4,503	$363K
78815	Positron emission tomography (PET) for limited area imaging	<1%	697	$300K
71045	Radiologic examination, chest; single view	<1%	63,079	$279K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	484	$270K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,110	$263K
80053	Comprehensive metabolic panel	<1%	98,399	$251K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	12,531	$239K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,593	$238K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,391	$223K
72110		<1%	1,860	$222K
73110		<1%	6,183	$220K
97113		<1%	2,724	$220K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	4,608	$217K
99222	Initial hospital care, per day, moderate complexity	<1%	2,705	$217K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	2,672	$217K
73030		<1%	8,412	$202K
76642		<1%	3,528	$201K
71250		<1%	2,920	$199K
92588		<1%	532	$197K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,731	$196K
70491		<1%	454	$195K
73564		<1%	2,248	$191K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	7,087	$190K
93798		<1%	2,903	$189K
72100		<1%	4,652	$187K
73610		<1%	5,512	$186K
97162		<1%	4,046	$184K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	58,252	$174K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	15,163	$172K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	800	$169K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	280	$161K
73562		<1%	6,228	$157K
72072		<1%	1,638	$154K
73130		<1%	5,965	$153K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	686	$150K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	2,911	$150K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	9,216	$146K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,104	$141K
77080		<1%	1,889	$141K
77066	Tomosynthesis, mammo	<1%	1,759	$141K
72040		<1%	2,142	$137K
73502		<1%	4,154	$136K
88342		<1%	4,673	$131K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	257	$131K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,690	$127K
87340		<1%	1,662	$127K
64493		<1%	166	$124K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	2,294	$117K
92550		<1%	1,101	$116K
77063	Screening digital breast tomosynthesis, bilateral	<1%	11,361	$114K
73630		<1%	6,128	$114K
97597		<1%	1,716	$113K
72141		<1%	1,013	$111K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,097	$108K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	8,096	$106K
84443	Thyroid stimulating hormone (TSH)	<1%	13,252	$104K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,607	$104K
95816		<1%	1,241	$104K
72128		<1%	1,340	$102K
92557		<1%	2,905	$102K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	4,279	$101K
76536		<1%	2,170	$99K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	6,318	$98K
87536		<1%	621	$97K
97161		<1%	5,525	$95K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	140	$93K
82652		<1%	1,916	$92K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	898	$90K
93880		<1%	1,016	$90K
72050		<1%	952	$90K
80048	Basic metabolic panel (calcium, ionized)	<1%	17,041	$89K
74178		<1%	363	$88K
87086	Culture, bacterial; quantitative colony count, urine	<1%	16,185	$82K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,447	$81K
99239	Hospital discharge day management, more than 30 minutes	<1%	1,284	$80K
80061	Lipid panel	<1%	22,441	$76K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,615	$73K
12001		<1%	917	$72K
84154		<1%	905	$68K
99223	Prolong inpt eval add15 m	<1%	623	$68K
20553		<1%	452	$68K
73221		<1%	641	$65K
73080		<1%	2,241	$64K
70486		<1%	1,403	$62K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,545	$61K
70496		<1%	1,000	$60K
Q4132	Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure)	<1%	71	$58K
80055		<1%	369	$58K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,017	$54K
76775		<1%	2,487	$54K
99217		<1%	1,359	$53K
73120		<1%	1,090	$53K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	454	$53K
99243		<1%	1,153	$51K
83970		<1%	1,390	$50K
87150		<1%	1,548	$48K
86703		<1%	3,132	$48K
71271		<1%	1,235	$48K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,797	$47K
86803		<1%	2,447	$47K
87641		<1%	1,537	$47K
81513		<1%	350	$46K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,158	$43K
73522		<1%	576	$42K
74183		<1%	188	$41K
76770		<1%	1,387	$39K
84702		<1%	3,856	$38K
84100		<1%	9,984	$37K
93017		<1%	2,690	$36K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	101,732	$36K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	34,589	$35K
87070		<1%	6,006	$35K
92587		<1%	160	$34K
20610		<1%	167	$34K
97535	Self-care/home management training, each 15 minutes	<1%	2,948	$34K
82043		<1%	4,167	$33K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	133	$33K
82951		<1%	1,300	$32K
99221		<1%	535	$32K
99204	Doctor's office visit, new patient (more involved)	<1%	549	$32K
87522	Neg quan hep c or qual rna	<1%	838	$30K
87081		<1%	5,299	$29K
74018		<1%	2,021	$29K
83880		<1%	8,789	$28K
87186		<1%	6,494	$28K
88142		<1%	1,197	$27K
36415	Collection of venous blood by venipuncture	<1%	158,924	$26K
73590		<1%	1,320	$26K
62323		<1%	85	$26K
83721		<1%	850	$26K
99219		<1%	362	$25K
94729		<1%	4,045	$25K
87507		<1%	171	$25K
99238	Hospital discharge day management, 30 minutes or less	<1%	563	$25K
73140		<1%	961	$25K
87480		<1%	2,377	$24K
73560		<1%	959	$24K
99215	Doctor's office visit, returning patient (complex)	<1%	725	$23K
86003		<1%	228	$23K
96375	Therapeutic injection; each additional sequential IV push	<1%	27,968	$23K
77065	Tomosynthesis, mammo	<1%	1,822	$22K
73090		<1%	1,123	$22K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	1,022	$21K
99220		<1%	217	$19K
86920		<1%	307	$19K
80074		<1%	1,468	$18K
72114		<1%	349	$18K
99225		<1%	538	$18K
74019		<1%	301	$18K
76870		<1%	981	$18K
84484		<1%	40,843	$17K
73620		<1%	651	$17K
74220		<1%	129	$17K
64483		<1%	59	$16K
88304		<1%	1,388	$16K
76830	Ultrasound, transvaginal	<1%	4,815	$16K
87653		<1%	385	$16K
82728		<1%	3,672	$16K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	3,468	$16K
96361	Intravenous infusion, hydration; each additional hour	<1%	13,373	$15K
12002		<1%	395	$14K
84481		<1%	1,624	$14K
88112		<1%	809	$14K
86039		<1%	464	$14K
97166		<1%	363	$14K
95812		<1%	200	$13K
93925		<1%	70	$13K
85610		<1%	16,559	$13K
12011		<1%	189	$12K
83690		<1%	21,268	$12K
87075		<1%	1,195	$12K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,139	$12K
84425		<1%	153	$12K
87077		<1%	1,962	$12K
84703		<1%	16,490	$12K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	35,779	$12K
81025		<1%	5,660	$12K
99205	Prolong outpt/office vis	<1%	150	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	17,905	$12K
0450	Emergency room services	<1%	300	$11K
76882		<1%	474	$11K
J1453	Injection, fosaprepitant, 1 mg	<1%	40	$11K
19083		<1%	12	$11K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	135	$11K
81001		<1%	42,444	$11K
10060		<1%	336	$10K
84156		<1%	865	$10K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	28,688	$10K
0352U		<1%	314	$10K
94726		<1%	3,656	$10K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	732	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	18,739	$9K
84153		<1%	1,700	$9K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	786	$9K
82024		<1%	29	$9K
77012		<1%	67	$9K
95806		<1%	145	$9K
77334		<1%	30	$8K
83001		<1%	172	$8K
82607		<1%	6,218	$8K
84030		<1%	728	$8K
99218		<1%	165	$8K
84439		<1%	16,779	$8K
J1815	Injection, insulin, per 5 units	<1%	6,317	$7K
29580		<1%	225	$7K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,039	$7K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	11,952	$7K
86592		<1%	3,259	$7K
82803		<1%	2,075	$7K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,391	$7K
85027		<1%	12,616	$7K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	6,350	$7K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	271	$7K
75574		<1%	122	$6K
84403		<1%	779	$6K
87040		<1%	6,377	$6K
97116		<1%	1,945	$6K
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,588	$5K
20611		<1%	34	$5K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	800	$5K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	9,560	$5K
87045		<1%	227	$5K
62321		<1%	15	$5K
96523		<1%	160	$4K
83605		<1%	15,261	$4K
J3490	Unclassified drugs	<1%	13,787	$4K
77427		<1%	43	$4K
93926		<1%	13	$4K
88341		<1%	322	$4K
73700		<1%	12	$4K
85060		<1%	225	$4K
76376		<1%	5,523	$4K
87205		<1%	2,923	$4K
86900		<1%	5,670	$4K
97165		<1%	387	$4K
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	47	$4K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,437	$4K
82950		<1%	222	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,640	$4K
86787		<1%	1,651	$4K
84480		<1%	215	$3K
86235		<1%	259	$3K
90715		<1%	3,306	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	8,941	$3K
86850		<1%	5,188	$3K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	84	$3K
93922		<1%	107	$3K
88300		<1%	519	$3K
71101		<1%	366	$3K
72202		<1%	68	$3K
76942		<1%	29	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	12,411	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	25,012	$2K
82670		<1%	158	$2K
86480		<1%	26	$2K
C1769	Guide wire	<1%	3,033	$2K
82247		<1%	1,023	$2K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	2,582	$2K
83615		<1%	396	$2K
84132		<1%	1,739	$2K
82746		<1%	3,972	$2K
99226		<1%	46	$2K
36591		<1%	467	$2K
83735		<1%	16,959	$2K
85378		<1%	4,116	$2K
99152		<1%	811	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	4,157	$2K
84146		<1%	25	$2K
36430		<1%	91	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,978	$2K
82105		<1%	153	$2K
76801		<1%	1,476	$2K
86038		<1%	1,170	$2K
80076		<1%	779	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,001	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,488	$2K
82948		<1%	19,521	$2K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	531	$2K
86701		<1%	575	$2K
83516		<1%	185	$1K
73000		<1%	35	$1K
85730		<1%	5,875	$1K
86141		<1%	114	$1K
82140		<1%	1,728	$1K
86769		<1%	80	$1K
85379		<1%	1,263	$1K
96415		<1%	731	$1K
87493		<1%	578	$1K
29125		<1%	520	$1K
82784		<1%	356	$1K
86762		<1%	1,053	$1K
84145		<1%	3,497	$1K
82550		<1%	3,200	$1K
83540		<1%	3,761	$1K
96367		<1%	3,607	$1K
84112		<1%	489	$993.21
J1630	Injection, haloperidol, up to 5 mg	<1%	315	$987.47
82533		<1%	66	$973.21
76937		<1%	316	$969.10
85014		<1%	205	$913.95
73060		<1%	71	$905.13
80164		<1%	74	$871.75
73565		<1%	33	$816.59
88141		<1%	40	$815.13
86901		<1%	5,899	$811.98
82947		<1%	2,394	$789.57
87510		<1%	2,376	$767.23
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	2,712	$711.61
86376		<1%	298	$689.61
99242		<1%	43	$687.52
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	21	$661.08
86756		<1%	472	$655.36
84436		<1%	4,094	$638.15
97032		<1%	90	$620.03
97802		<1%	15	$602.19
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	1,913	$580.46
73552		<1%	46	$563.24
J1650	Injection, enoxaparin sodium, 10 mg	<1%	4,427	$560.38
73100		<1%	15	$557.60
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,500	$523.19
81003		<1%	4,917	$506.03
87660		<1%	2,374	$490.83
86706		<1%	111	$465.82
82270		<1%	690	$446.67
J1644	Injection, heparin sodium, per 1000 units	<1%	5,725	$446.54
82627		<1%	86	$442.16
J1953	Injection, levetiracetam, 10 mg	<1%	83	$435.23
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	132	$401.33
72170		<1%	74	$393.24
76881		<1%	43	$389.31
84295		<1%	1,502	$387.93
83655		<1%	54	$374.82
92579		<1%	12	$350.90
86200		<1%	135	$344.22
J8540	Dexamethasone, oral, 0.25 mg	<1%	5,350	$343.64
J2060	Injection, lorazepam, 2 mg	<1%	4,004	$336.90
86160		<1%	13	$328.08
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	1,735	$302.25
86635		<1%	12	$295.12
97010		<1%	3,014	$285.99
86140		<1%	5,765	$283.88
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	320	$277.90
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,821	$258.14
83550		<1%	3,383	$250.60
96417		<1%	203	$244.39
82330		<1%	104	$236.48
86403		<1%	28	$236.26
99442		<1%	45	$235.48
97164		<1%	19	$229.87
86800		<1%	15	$223.63
J0456	Injection, azithromycin, 500 mg	<1%	330	$213.85
96376		<1%	11,010	$196.45
J2270	Injection, morphine sulfate, up to 10 mg	<1%	8,186	$195.73
82009		<1%	1,881	$194.37
C1776	Joint device (implantable)	<1%	1,682	$180.09
L1906	Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf	<1%	98	$175.33
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	762	$161.46
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	196	$158.84
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	6,743	$157.66
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,440	$154.11
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,149	$148.34
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,251	$146.35
88313		<1%	17	$145.34
97035		<1%	245	$141.77
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	3,646	$140.87
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	17,251	$140.09
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,155	$138.07
Q3014	Telehealth originating site facility fee	<1%	473	$137.66
94762		<1%	1,971	$130.74
86780		<1%	28	$127.68
92567		<1%	690	$126.56
A9270	Non-covered item or service	<1%	4,300	$118.71
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	222	$116.81
82565		<1%	276	$109.46
C1729	Catheter, drainage	<1%	852	$107.64
82570		<1%	3,860	$104.68
85652		<1%	6,009	$101.79
77001		<1%	104	$99.21
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	110	$98.39
76377		<1%	237	$93.93
J2704	Injection, propofol, 10 mg	<1%	11,443	$92.80
J7050	Infusion, normal saline solution, 250 cc	<1%	10,872	$91.21
86308		<1%	28	$80.62
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	858	$78.72
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	202	$76.30
80177		<1%	27	$70.71
96368		<1%	800	$63.52
88311		<1%	15	$61.20
82785		<1%	68	$56.56
82010		<1%	492	$55.86
77002		<1%	34	$53.08
85007		<1%	3,020	$52.27
82435		<1%	1,491	$50.83
87899		<1%	396	$49.62
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,919	$43.00
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	214	$42.95
94760		<1%	850	$42.18
E0114	Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips	<1%	495	$37.75
88302		<1%	59	$36.27
84520		<1%	126	$35.99
J1940	Injection, furosemide, up to 20 mg	<1%	1,537	$33.06
95012		<1%	93	$32.61
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,059	$31.41
84550		<1%	1,183	$30.02
J0280	Injection, aminophyllin, up to 250 mg	<1%	384	$27.84
C9113	Injection, pantoprazole sodium, per vial	<1%	3,355	$27.31
J1790	Injection, droperidol, up to 5 mg	<1%	832	$26.07
86431		<1%	1,106	$25.56
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,165	$23.70
84479		<1%	2,284	$22.27
94668		<1%	14	$20.84
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	<1%	700	$19.99
86702		<1%	576	$18.15
51702		<1%	372	$10.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	648	$9.10
81005		<1%	244	$7.19
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	730	$6.49
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,453	$6.38
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	3,624	$5.59
J2470	Injection, pantoprazole sodium, 40 mg	<1%	81	$4.78
85018		<1%	262	$2.07
S0028	Injection, famotidine, 20 mg	<1%	1,768	$1.90
A4215	Needle, sterile, any size, each	<1%	3,191	$1.65
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,315	$0.90
J3411	Injection, thiamine hcl, 100 mg	<1%	993	$0.24
J8597	Antiemetic drug, oral, not otherwise specified	0%	323	$0.00
88738		0%	2,051	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	5,609	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	370	$0.00
87640		0%	1,181	$0.00
94761		0%	1,355	$0.00
86593		0%	277	$0.00
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	0%	441	$0.00
83002		0%	41	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	61	$0.00
84402		0%	442	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	65	$0.00
84144		0%	14	$0.00
64494		0%	134	$0.00
J3535	Drug administered through a metered dose inhaler	0%	298	$0.00
97014		0%	38	$0.00
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	408	$0.00
C9399	Unclassified drugs or biologicals	0%	197	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	531	$0.00
A4648	Tissue marker, implantable, any type, each	0%	203	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	703	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	474	$0.00
87015		0%	73	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	259	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	167	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	470	$0.00
97018		0%	29	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	57	$0.00
J1836	Injection, metronidazole, 10 mg	0%	140	$0.00
97610		0%	42	$0.00
87807		0%	43	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	20	$0.00
86704		0%	21	$0.00
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	0%	78	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	140	$0.00
86225		0%	13	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	33	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	26	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	42	$0.00
36471		0%	21	$0.00
A6260	Wound cleansers, any type, any size	0%	28	$0.00
74022		0%	13	$0.00
C1781	Mesh (implantable)	0%	13	$0.00
J0583	Injection, bivalirudin, 1 mg	0%	12	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	14	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	78	$0.00
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	0%	13	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	64	$0.00
87503		0%	18	$0.00
G0008	Administration of influenza virus vaccine	0%	14	$0.00
J1626	Injection, granisetron hydrochloride, 100 mcg	0%	22	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	737	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	563	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	1,325	$0.00
S0077	Injection, clindamycin phosphate, 300 mg	0%	359	$0.00
87535		0%	15	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	70	$0.00
82248		0%	182	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	65	$0.00
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	0%	844	$0.00
A6254	Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	183	$0.00
76000		0%	89	$0.00
83525		0%	26	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	282	$0.00
51701		0%	24	$0.00
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	45	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	525	$0.00
91040		0%	31	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	613	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	54	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	347	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	43	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	470	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	15	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	305	$0.00
A6457	Tubular dressing with or without elastic, any width, per linear yard	0%	83	$0.00
A4565	Slings	0%	243	$0.00
36600		0%	50	$0.00
J8499	Prescription drug, oral, non chemotherapeutic, nos	0%	94	$0.00
C1758	Catheter, ureteral	0%	172	$0.00
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	0%	145	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	98	$0.00
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	20	$0.00
77336		0%	132	$0.00
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	0%	151	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	131	$0.00
94669		0%	31	$0.00
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	0%	57	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	15	$0.00
87538		0%	15	$0.00
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	0%	34	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	17	$0.00
L0140	Cervical, semi-rigid, adjustable (plastic collar)	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBLANCHARD, TIM (CFO)

Same official

Other billing entities under BLANCHARD, TIM

Full network →

Provider	Location	Paid
Kingman Healthcare, INC	Kingman, AZ	$3.84M
Kingman Healthcare, INC	Kingman, AZ	$193K
Kingman Healthcare, INC	Kingman, AZ	$731.12

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.